Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Awareness of Hypoglycemia in Type 1 Diabetes: A Randomized Controlled Trial.

van Meijel, Lian A; Rooijackers, Hanne M; Tack, Cees J; de Galan, Bastiaan E

van Meijel, Lian A; Rooijackers, Hanne M; Tack, Cees J; de Galan, Bastiaan E.

Afiliação

van Meijel LA; Department of Internal Medicine, Radboud University Medical Center, HB Nijmegen, Netherlands.
Rooijackers HM; Department of Internal Medicine, Radboud University Medical Center, HB Nijmegen, Netherlands.
Tack CJ; Department of Internal Medicine, Radboud University Medical Center, HB Nijmegen, Netherlands.
de Galan BE; Department of Internal Medicine, Radboud University Medical Center, HB Nijmegen, Netherlands.

J Clin Endocrinol Metab ; 104(9): 4143-4150, 2019 Sep 01.

Article em En | MEDLINE | ID: mdl-30958544

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google